ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer

BACKGROUND: The efficacy of docetaxel-based chemotherapy is limited by the development of drug resistance. Recent studies demonstrated the efficacy of anti-programmed death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) immunotherapies in metastatic prostate cancer. The ataxia telangiectasia mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zongren, Zhang, Xueling, Li, Wuguo, Su, Qiao, Huang, Zhaoyang, Zhang, Xinyao, Chen, Haiqi, Mo, Chengqiang, Huang, Bin, Ou, Wei, Chen, Junxing, Zhao, Guangyin, Chen, Lingwu, Shao, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296819/
https://www.ncbi.nlm.nih.gov/pubmed/34301812
http://dx.doi.org/10.1136/jitc-2020-001758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296819/
https://www.ncbi.nlm.nih.gov/pubmed/34301812
http://dx.doi.org/10.1136/jitc-2020-001758

Ejemplares similares